Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT HARMONY BIOSCIENCES HOLDINGS, INC.

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY)
Listen to this Section


$32.69
-0.2750 ( -0.83% ) 130.7K

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

Market Data


Open $32.69
Previous Close $32.96
Volume 130.7K
Market Cap $1.86B
Day Range $32.65 - $33.23
52 Week Range $25.52 - $40.87
Shares Outstanding 57.89M
Change % -0.83%
Net Change ▼ -0.2750
Insider Ownership -0.82%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -499,380.00

Date Type Amount Purchased Purchaser
2024-05-31 Sale -6336.00 Graf R. Mark
2024-05-31 Sale -6336.00 Szyper Linda M
2024-05-31 Sale -6336.00 Anastasiou Peter
2024-05-31 Sale -6336.00 Nielsen Jack
2024-05-31 Sale -8870.00 Gracias Antonio J.
2024-05-31 Sale -11657.00 Sender Gary
2024-05-31 Sale -6336.00 Sabater Juan A.
2024-05-03 Sale -75000.00 Budur Kumar
2024-04-02 Sale -15000.00 Kapadia Sandip
2024-03-18 Sale -11979.00 Dierks Jeffrey

SEC Filings


Form Type Description Pages Date
8-k 8K-related 33 Nov 04, 2025
10-q Quarterly Reports 92 Nov 04, 2025
8-k 8K-related 15 Oct 23, 2025
4 Insider transactions 1 Oct 02, 2025
8-k 8K-related 14 Sep 24, 2025
4 Insider transactions 1 Sep 02, 2025
4 Insider transactions 1 Aug 19, 2025
8-k 8K-related 32 Aug 05, 2025
10-q Quarterly Reports 93 Aug 05, 2025
8-k 8K-related 14 Jun 11, 2025

Latest News


× Before browsing our site, please accept our cookies policy